Immune-evasive

Herve, M., et al. (2003). Pivotal roles of the parasite PGD2 synthase and of the host D prostanoid receptor 1 in schistosome immune evasion. Eur. J. Immunol 33, 2764-72. 

Smith, H.V. (1991) Immune evasion and immunopathology in Toxocara canis infection. In Kennedy, M.W. (ed.) Parasitic Nematodes —Antigens, Membranes and Genes. Taylor and Francis, London, pp. 116-139. 

Dinkla, K., Rohde, M., Jansen, W. M. T., Carapetis, J. R., Chhatwal, G. S., and Talay, S. R. (2003). Streptococcus pyogenes recruits collagen via surface-bound fibronectin A novel colonization and immune evasion mechanism. Mol. Microbiol. 47, 861-869. 

Feuh, K., et ah. Immune evasion by a novel family of viral PHD/LAP-finger proteins of gamma-2 herpesviruses and poxviruses. Virus Res, 2002, 88(1-2), 55-69. 

Bartee, E., et ah, Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins. J Virol, 2004, 78(3), 1109-20. 

Semnani RT, Law M, Kubofeik J, Nutman TB Filaria-induced immune evasion suppression by the infective stage of Brugia malayi at the earliest host-parasite interface. J Immunol 2004 172 6229-6238. 

Fink J, Ferrone S, Frey A. Where have all the T-cells gone Mechanisms of immune evasion by tumors. Immunol Today 1999 20 158. 

Ploegh HL (1998) Viral strategies of immune evasion. Science 280 248-253. 

Hoskin DW, Mader JS, Furlong SJ, Conrad DM, Blay J (2008) Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (review). Int J Oncol 32(3) 527-535... 

Herve, M., Angeli, V., Pinzar, E., Wintjens, R., Faveeuw, C., Narumiya, S., Capron, A., Urade, Y., Capron, M., Riveau, G. andTrottein, F. (2003) Pivotal roles of the parasite PGD2 synthase and of the host D prostanoid receptor 1 in schistosome immune evasion. European Journal of Immunology 33, 2764-2772. 

Pearce, E.J. and Sher, A. (1987) Mechanisms of immune evasion in schistosomiasis. Contributions in Microbiology Immunology 8, 21 9-232. 

Dessein, A., Samuelson, J.C., Butterworth, A.E., Hogan, M., Sherry, B.A., Vadas, M.A. and David, J.R. (1981) Immune evasion by Schistosoma mansoni loss of susceptibility to antibody or complement-dependent eosinophil attack by schistosomula cultured in medium free of macromolecules. Parasitology 82, 357-374. 

Alcami, A. and Koszinowski, U.H. 2000. Viral mechanisms of immune evasion. Trends Microbiol. 8, 410-418. 

Many SCLC patients mount an antitumor immune response without signs of PNS [9, 167, 174]. Nevertheless, most SCLC patients do not have this immune response. Thus, the rarity of PNS cannot be attributed to infrequency of antigen expression. This discrepancy suggests that additional factors, perhaps related to tumor major histocompatibility complex (MHC) expression, contribute to the initiation of the PNS immune response. A study of Hu antigen and MHC class I expression in SCLC and neuroblastoma supports this theory. Seventeen of 20 tumors from Hu antibody positive patients expressed both proteins, but only 4 of 30 specimens from seronegative individuals expressed both proteins [171]. Altered expression and/or down-regulation of MHC molecules is a common immune-evasive strategy of tumor cells [175],... 

Salek-Ardakani S, Arrand JR, Mackett M. Epstein-Barr virus encoded interleukin-10 inhibits HLA-class I, ICAM-1, and B7 expression on human monocytes implications for immune evasion by EBV. Virology 2002 304 342-51. 

---